Pain Management

Trolamine salicylate is a pain-relieving compound closely related to aspirin, a nonsteroidal anti-inflammatory drug.

Pharmacists can encourage patients to ask prescribers about newly approved preventive therapies when appropriate.

Patients were randomized 1:1 to receive either erenumab or topiramate, with the erenumab arm split into dosages of 70 mg or 140 mg.

Pharmacists Can Provide Advice on Pain Products’ Directions, Dosage, and Duration of Use

Individuals taking erenumab had a 55.4% reduction from baseline in their monthly migraine days, results from HER-MES show.

Use lowest effective dosages to prevent constipation, sedation, respiratory depression, and more.

Voltaren treats osteoarthritis pain in the joints amenable to topical treatment, such as the knees and the hands.

Preparation H works by temporarily narrowing the blood vessels in the area, which decreases swelling and discomfort caused by hemorrhoids.

Ten quiz questions to assess your knowledge on common symptoms and treatments for migraine headaches.

Those aged 18 to 34 years self-treat with cannabidiol or cannabis at 2 times the rate of people aged 45 years or older.

An effective therapeutic treatment for acute or chronic pain needs to be convenient, easy to self-administer, and have rapid onset to provide fast relief.

Individuals with bruxism may unconsciously clench their teeth when awake or grind teeth during sleep.

Celecoxib and tramadol hydrochloride (Seglentis; Esteve Pharmaceuticals) is an oral prescription with a unique co-crystal formulation of the anti-inflammatory drug, celecoxib, and the schedule IV opioid analgesic drug, tramadol.

Officials with the FDA have approved Zimhi 5 mg/0.5 mL, a high-dose naloxone injection product, for use in the treatment of opioid overdose.

In an interview with Pharmacy Times®, Mitchell Barnett, PharmD, MS, associate director of the Iowa Prescription Monitoring Program for the Iowa Board of Pharmacy, and Mylo Wells, PharmD, owner of Wells Hometown Drug, discuss Iowa’s new drug disposal kit program and the impact it could have on the opioid epidemic.

Symptoms of fibromyalgia often begin after an event, such as physical trauma, surgery, infection, or significant psychological stress.

Significant reductions in mean monthly migraine days compared with placebo were seen as early as weeks 1 through 4 in the clinical trial program for atogepant.

Schedule I drugs, substances, or chemicals are defined as medications with no currently accepted medical use and a high potential for abuse.

Funded by a grant from the National Institutes of Health, this trial is intended to test the safety and efficacy of a vaccine designed to selectively prevent the euphoric and toxic effects of oxycodone.

September is National Recovery Month, so Pharmacy Times interviewed Rich Dion, PharmD, of Wolters Kluwer, Health, on the critical role of the hospital pharmacist in ongoing efforts to fight the opioid epidemic.

Pharmacists can be instrumental in reducing the main challenges in opioid use disorder—namely supply, demand, and harm.

The AHA worked with a team of leading health authorities to develop the advisory, which highlights recommendations, algorithms, and guidance for health care professionals and researchers who specialize in heart and brain health.

Study findings could influence how drug developers consider how opioid drugs cause tolerance and respiratory depression, and it suggests an alternative approach to developing safer analgesics.

Pharmacists carry a unique responsibility in the battle that has claimed 500,000 lives in the past 2 decades.

For the study, approximately 20,000 people were followed over a span of 4 years, which showed that reports of marijuana use peaked at 9% for patients with cancer versus 14% among those with no cancer history.

Nicholas Mathews, co-founder of Stillwater Behavioral Health, discusses how pharmacists can respond to the identification of potentially problematic opioid prescription practices at sober-living facilities.

Thomas Maggio, MBA, public affairs and engagement manager at AACP, discussed his presentation assessing the Opioid-Related Activity Database and its impact in showing the efforts of pharmacists and student pharmacists to fight the opioid epidemic.

Advice to community pharmacists and patients who suffer from migraine on strategies that can improve quality of life and be used to navigate the care continuum.

Red flags that would prompt a pharmacist to refer a patient with migraine to be evaluated by a physician.

What community pharmacists need to know about migraine treatment and their role in educating and managing patients.